Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single-arm, phase 2 study evaluating the efficacy and safety of combination of lenalidomide and R-ICE in patients of relapsed/refractory non-GCB subtype DLBCL previously treated with R-CHOP

Trial Profile

A single-arm, phase 2 study evaluating the efficacy and safety of combination of lenalidomide and R-ICE in patients of relapsed/refractory non-GCB subtype DLBCL previously treated with R-CHOP

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs Carboplatin (Primary) ; Etoposide (Primary) ; Ifosfamide (Primary) ; Lenalidomide (Primary) ; Rituximab (Primary)
  • Indications Diffuse large B cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top